Edition:
India

Kaustubh Kulkarni

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

14 Aug 2013

Hope fades for 18 on submarine after blasts, fire

MUMBAI India's navy chief held out little hope for survivors on a submarine after some of its weapons detonated accidentally and fire swept through it. The likely deaths and damage are the worst blow to the navy since a 1971 war with Pakistan.

14 Aug 2013

Hope fades for 18 on Indian submarine after blasts, fire

MUMBAI India's navy chief held out little hope for survivors on a submarine after some of its weapons detonated accidentally and fire swept through it. The likely deaths and damage are the worst blow to the navy since a 1971 war with Pakistan. | Video

14 Aug 2013

Hope fades for 18 on Indian submarine after blasts, fire

MUMBAI India's navy chief held out little hope for survivors on a submarine after some of its weapons detonated accidentally and fire swept through it. The likely deaths and damage are the worst blow to the navy since a 1971 war with Pakistan. | Video

09 Aug 2013

India revokes patents on Allergan eye drugs Ganfort and Combigan

MUMBAI India revoked patents on two of Allergan Inc's eye drugs on Thursday, the latest in a series of intellectual property setbacks suffered by Western drugmakers.

09 Aug 2013

India revokes patents on Allergan eye drugs Ganfort and Combigan

MUMBAI India revoked patents on two of Allergan Inc's eye drugs on Thursday, the latest in a series of intellectual property setbacks suffered by Western drugmakers.

09 Aug 2013

India revokes patents on Allergan eye drugs Ganfort and Combigan

MUMBAI, Aug 8 India revoked patents on two of Allergan Inc's eye drugs on Thursday, the latest in a series of intellectual property setbacks suffered by Western drugmakers.

03 Aug 2013

India revokes GSK cancer drug patent in Pharma blow

MUMBAI India has revoked a patent granted to GlaxoSmithKline Plc for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental innovations that was a blow to global pharmaceutical firms.

02 Aug 2013

India revokes GSK cancer drug patent in latest Big Pharma blow

MUMBAI India has revoked a patent granted to GlaxoSmithKline Plc for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental innovations that was a blow to global pharmaceutical firms.

02 Aug 2013

India revokes GSK cancer drug patent in latest Big Pharma blow

MUMBAI India has revoked a patent granted to GlaxoSmithKline Plc for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental innovations that was a blow to global pharmaceutical firms.

02 Aug 2013

India revokes GSK cancer drug patent in latest Big Pharma blow

MUMBAI India has revoked a patent granted to GlaxoSmithKline Plc for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental innovations that was a blow to global pharmaceutical firms.

Markets

  • Asia
  • U.S.
  • Europe
  • Sectors
Stock Search
Sensex 33,342.80 + 235.98 +0.71%
Nikkei 22,396.80 + 45.68 +0.20%
Hang Seng 29,199.04 + 180.28 +0.62%
EUR/INR 76.621 -0.03%
USD/INR 65.010 +0.00%
GBP/INR 85.872 +0.02%
Gold 1,288.30 +10.80 +0.85%
Oil 56.55 +0.00 +0.00%
Corn 343.00 +0.00 +0.00%